Status:
UNKNOWN
Improvement of Neuromuscular Function, Fatigue and Quality of Life by Optimizing Muscle Building and Nutrition in Colorectal Cancer: a Pilot Study
Lead Sponsor:
Ramsay Générale de Santé
Collaborating Sponsors:
Dr Laurent GERGELE
Conditions:
Cancer
Cachexia; Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is based on the assumption that muscle strength and muscle mass will be better preserved in an "intervention" group with specific management combining retraining and nutritional monitoring ...
Detailed Description
Cancer patients have a significant risk of losing muscle mass, mainly related to cachexia, as a result of metabolic changes associated with the tumor process and treatments. However, it is reinforced ...
Eligibility Criteria
Inclusion
- Patient, male or female, over 18 years old
- Patient operated on for a first colorectal cancer (adenocarcinoma) and requiring adjuvant chemotherapy
- Patient with the consent of a physician to participate in the innovative muscle building program
- Patient able to go at least once a week for 12 weeks to the Private Hospital of the Loire in Saint-Etienne (the other 2 weekly sessions that can take place in the patient's home)
- Patient affiliated or beneficiary of a social security scheme
- Patient having signed the free and informed consent
Exclusion
- Comorbidities potentially affecting participation or test results (unstable, neuromuscular, musculoskeletal or vascular diseases affecting the lower limbs, such as radiculopathy, myopathy or neuropathy)
- Technical necessity to convert laparoscopy into laparostomy
- Patient unable to follow verbal instructions that could affect test and / or exercise procedures
- Patient participating in another clinical study
- Protected patient: major under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
- Pregnant, lactating or parturient woman
- Patient hospitalized without consent.
Key Trial Info
Start Date :
November 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04136249
Start Date
November 2 2019
End Date
April 30 2022
Last Update
March 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Privé de la Loire 39
Saint-Étienne-de-Montluc, Pays de la Loire Region, France, 42100